JV
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Assessment of access and outcomes of kidney transplantation through the reforms of the Swiss organ allocation system | Frontiers in public health | 2025 | 121 | 193 | |||
| Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer | Science advances | 2025 | 92 | 212 | |||
| Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO) | Transplantation direct | 2025 | 17 | 49 | |||
| Comparing variable and feature selection strategies for prediction - protocol of a simulation study in low-dimensional transplantation data | PloS one | 2025 | 18 | 148 | |||
| Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in Switzerland | Kidney international reports | 2025 | 107 | 190 | |||
| Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis | Kidney international reports | 2025 | 51 | 321 | |||
| Invasive Candida infections in solid organ transplant recipients between 2008 and 2020 | American Journal of Transplantation | 2025 | 24 | 92 | |||
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | 2025 | 75 | 212 | |||
| Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy : results of SAKK 11/16, a phase IIa trial | Experimental hematology & oncology | 2025 | 60 | 58 | |||
| A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors | Cancer research communications | 2024 | 110 | 175 | |||
| Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study | BMC infectious diseases | 2024 | 65 | 128 | |||
| Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ? | Open forum infectious diseases | 2024 | 115 | 115 | |||
| Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients | Transplant international | 2024 | 113 | 137 | |||
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | 2024 | 50 | 104 | |||
| Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The Journal of infectious diseases | 2024 | 522 | 581 | |||
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | 2024 | 61 | 223 | |||
| Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | 2024 | 89 | 36 | |||
| Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter study | Bone marrow transplantation | 2024 | 84 | 87 | |||
| NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation | Blood advances | 2024 | 115 | 100 | |||
| Néphrologie solidaire : la coopération Genève-Yaoundé | Revue médicale suisse | 2023 | 88 | 360 | |||
| Vaccine-preventable infections among solid organ transplant recipients in Switzerland | JAMA network open | 2023 | 139 | 170 | |||
| Donor-derived fulminant herpes simplex virus hepatitis after liver transplantation : Two cases and review of literature | Transplant infectious disease | 2023 | 136 | 172 | |||
| Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | 2023 | 160 | 52 | |||
| CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation | Leukemia & lymphoma | 2023 | 77 | 87 | |||
| Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients : The STOP-FLU trial | Clinical infectious diseases | 2023 | 107 | 195 | |||
| Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | 2023 | 79 | 232 | |||
| An automated histological classification system for precision diagnostics of kidney allografts | Nature medicine | 2023 | 102 | 0 | |||
| Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial | Clinical infectious diseases | 2023 | 150 | 275 | |||
| Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | 2023 | 94 | 90 | |||
| Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological Update | Open forum infectious diseases | 2023 | 128 | 126 | |||
| Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation | Frontiers in immunology | 2023 | 84 | 81 | |||
| Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | 2023 | 146 | 107 | |||
| HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era | HLA | 2023 | 108 | 95 | |||
| The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study | Frontiers in immunology | 2022 | 195 | 108 | |||
| Personalized immunotherapy with encapsulated cell technology : Feasibility, safety and efficacy results from the first-in-human clinical trial in advanced relapsing solid tumors | ESMO Congress 2022 | 2022 | 94 | 161 | |||
| Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHD | Blood | 2022 | 505 | 165 | |||
| Regulation of HLA class I expression by non-coding gene variations | PLOS genetics | 2022 | 176 | 287 | |||
| A National Survey Comparing Patients' and Transplant Professionals' Research Priorities in the Swiss Transplant Cohort Study | Transplant international | 2022 | 213 | 128 | |||
| Atopy as an independent predictor for long-term patient and graft survival after kidney transplantation | Frontiers in rheumatology & clinical immunology | 2022 | 176 | 39 | |||
| Use of statins after liver transplantation is associated with improved survival: results of a nationwide study | Alimentary pharmacology & therapeutics | 2022 | 153 | 258 | |||
| Antibody‐mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments | Clinical transplantation | 2022 | 136 | 1,183 | |||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 245 | 143 | |||
| Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | 2022 | 201 | 186 | |||
| Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation | Blood advances | 2021 | 321 | 135 | |||
| Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study | PLOS ONE | 2021 | 328 | 400 | |||
| Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 | Antimicrobial resistance and infection control | 2021 | 386 | 157 | |||
| Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | 2021 | 364 | 1 | |||
| Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation | Leukemia | 2020 | 406 | 313 | |||
| Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination | NPJ Vaccines | 2020 | 480 | 140 | |||
| CD8+ T-Cell Repertoire in Human Leukocyte Antigen Class I-Mismatched Alloreactive Immune Response | Frontiers in Immunology | 2020 | 244 | 226 | |||
| Immunologic clearance of a BK virus-associated metastatic renal allograft carcinoma | Transplantation | 2020 | 349 | 421 | |||
| Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy | Pediatric Transplantation | 2020 | 411 | 2 | |||
| HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation | Blood | 2020 | 362 | 0 | |||
| Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation | Journal of Clinical Oncology | 2020 | 191 | 0 | |||
| Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study | Clinical Infectious Diseases | 2020 | 346 | 244 | |||
| Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT | Human Immunology | 2020 | 201 | 13 | |||
| Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study | The Lancet. Haematology | 2020 | 276 | 0 | |||
| Peripheral donor specific antibodies are associated with histology and cellular subtypes in protocol liver biopsies of pediatric recipients | Transplantation | 2020 | 373 | 211 | |||
| Natural Killer Cell Alloreactivity Against Human Induced Pluripotent Stem Cells and Their Neuronal Derivatives into Dopaminergic Neurons | Stem Cells and Development | 2020 | 314 | 1 | |||
| Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease | Rheumatology | 2020 | 333 | 9 | |||
| Vitamin d status and risk of infections after liver transplantation in the swiss transplant cohort study | Transplant International | 2019 | 553 | 0 | |||
| Management of allergy transfer upon solid organ transplantation | American Journal of Transplantation | 2019 | 397 | 292 | |||
| High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation | Bone Marrow Transplantation | 2019 | 459 | 149 | |||
| Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study | Transplant Infectious Disease | 2018 | 593 | 0 | |||
| Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection | Journal of Clinical Investigation | 2018 | 473 | 225 | |||
| Identification of seven novel HLA class I and II alleles | HLA | 2018 | 254 | 0 | |||
| Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective study | BMC Nephrology | 2018 | 555 | 216 | |||
| LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions | Journal of Clinical Investigation | 2018 | 484 | 228 | |||
| Factors associated with immune hemolytic anemia after pediatric liver transplantation | Pediatric Transplantation | 2018 | 384 | 1 | |||
| Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine | The Pharmacogenomics Journal | 2018 | 663 | 387 | |||
| A Systematic Review and Meta-Analysis of HCV Clearance | Liver international | 2017 | 606 | 1 | |||
| The HLA-B landscape of Africa: Signatures of pathogen-driven selection and molecular identification of candidate alleles to malaria protection | Molecular Ecology | 2017 | 647 | 593 | |||
| Identification of 3 novel HLA-B alleles: B*08:173, B*18:72:03 and B*53:05:02 | HLA | 2017 | 560 | 0 | |||
| Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation | Cell transplantation | 2016 | 557 | 3 | |||
| Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro | Transplantation direct | 2016 | 693 | 526 | |||
| A significant effect of the killer cell immunoglobulin-like receptor ligand human leucocyte antigen-C on fibrosis progression in chronic C hepatitis with or without liver transplantation | Liver international | 2016 | 566 | 1 | |||
| Identification of the novel HLA-B*07:261 allele | HLA | 2016 | 544 | 0 | |||
| Felty's syndrome and hypofibrinogenemia: an unusual target for anti-cyclic citrullinated peptide antibodies? | Modern rheumatology | 2015 | 691 | 0 | |||
| Kidney paired donation: a plea for a Swiss National Programme | Schweizerische medizinische Wochenschrift | 2015 | 722 | 388 | |||
| Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial Presentation | Transplantation direct | 2015 | 515 | 2 | |||
| Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab | Annals of hematology | 2015 | 611 | 2 | |||
| Long-term follow-up of cadaveric breast augmentation: what can we learn? | Aesthetic surgery journal | 2015 | 638 | 2 | |||
| Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies | Bone marrow research | 2015 | 588 | 215 | |||
| Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes | Transplantation | 2015 | 544 | 0 | |||
| Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy | Journal of immunology research | 2014 | 516 | 0 | |||
| Prédispositions génétiques dans l'allergie médicamenteuse : importance du HLA | Revue médicale suisse | 2014 | 523 | 0 | |||
| KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients | Genes and immunity | 2014 | 681 | 0 | |||
| Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation | Transplant immunology | 2014 | 698 | 2 | |||
| Interaction of ES cell derived neural progenitor cells with natural killer cells and cytotoxic T cells | Methods in molecular biology | 2013 | 670 | 2 | |||
| The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children | PloS one | 2013 | 729 | 426 | |||
| Transplanted human pancreatic islets after long-term insulin independence | American journal of transplantation | 2013 | 871 | 1 | |||
| The role of immunosuppression in the transplantation of allogenic neural precursors derived from human pluripotent stem cells for Parkinson's disease | Stem cell research & therapy | 2013 | 1,001 | 355 | |||
| Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy | Leukemia | 2012 | 1,272 | 681 | |||
| HLA and non-HLA polymorphisms in renal transplantation | Schweizerische medizinische Wochenschrift | 2012 | 666 | 1 | |||
| Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation | Pediatric transplantation | 2012 | 732 | 0 | |||
| Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations | Stem cells and development | 2012 | 695 | 889 | |||
| Posttransplant cellular immune reactivity against donor antigen correlates with clinical islet transplantation outcome: towards a better posttransplant monitoring | Cell transplantation | 2012 | 617 | 0 | |||
| Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients | HIV medicine | 2012 | 726 | 0 | |||
| Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe? | Tissue antigens | 2012 | 706 | 0 | |||
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | 2011 | 1,056 | 668 | |||
| Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients | Clinical journal of the American Society of Nephrology | 2011 | 619 | 0 | |||
| Introduction: Immunopathology and the promise of stem cell research | Seminars in immunopathology | 2011 | 650 | 144 | |||
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | 2011 | 884 | 8 | |||
| Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation | American journal of transplantation | 2011 | 752 | 0 | |||
| Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity | Cell transplantation | 2011 | 703 | 0 | |||
| De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients | American journal of transplantation | 2011 | 668 | 0 | |||
| How to cross immunogenetic hurdles to human embryonic stem cell transplantation | Seminars in immunopathology | 2011 | 635 | 372 | |||
| The role of natural killer cells in human solid organ and tissue transplantation | Journal of innate immunity | 2011 | 585 | 0 | |||
| Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation | Transplantation | 2010 | 661 | 0 | |||
| Early relapse of autoimmune glomerulonephritis after kidney transplantation despite antibody induction and triple-drug-based immunosuppression | Transplantation | 2010 | 657 | 0 | |||
| Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients | Clinical immunology | 2010 | 652 | 0 | |||
| The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation | The Journal of immunology | 2009 | 718 | 0 | |||
| Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells | Journal of Cellular and Molecular Medicine | 2009 | 611 | 168 | |||
| Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients | Transplant international | 2009 | 649 | 0 | |||
| Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark | American journal of transplantation | 2009 | 982 | 6 | |||
| Sequence of a novel HLA-A2 allele in a haematopoietic stem cell donor of the international registry | Tissue antigens | 2009 | 636 | 0 | |||
| Pluripotent stem cells as new drugs? The example of Parkinson's disease | International journal of pharmaceutics | 2009 | 784 | 3 | |||
| A new HLA-DR4 allele, DRB1*0474, with an unusual residue at position 77 | Tissue antigens | 2008 | 643 | 1 | |||
| Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation | Transplantation | 2008 | 928 | 0 | |||
| Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation | American journal of transplantation | 2008 | 777 | 0 | |||
| IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes | International immunology | 2008 | 579 | 164 | |||
| DNA typing by microbead arrays and PCR-SSP: apparent false-negative or -positive hybridization or amplification signals disclose new HLA-B and -DRB1 alleles | Tissue antigens | 2008 | 586 | 0 | |||
| Human herpesvirus-6 variant A encephalomyelitis | Neurology | 2008 | 676 | 0 | |||
| The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors | Arthritis Research and Therapy | 2007 | 244 | 219 | |||
| Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab | Transplant international | 2007 | 855 | 0 | |||
| Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine | Experimental Hematology | 2007 | 201 | 0 | |||
| Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance | Antimicrobial Agents and Chemotherapy | 2007 | 271 | 0 | |||
| Investigation of alloreactive NK cells in mixed lymphocyte reactions using paraformaldehyde-silenced target cells | Journal of Immunological Methods | 2007 | 203 | 0 | |||
| Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications | Blood | 2006 | 641 | 0 | |||
| Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation | Schweizerische medizinische Wochenschrift | 2006 | 531 | 394 | |||
| Acute humoral rejection in kidney allograft following a third-party arterial transplantation | American journal of transplantation | 2006 | 635 | 0 | |||
| Differentiation between atypical isolates of Candida lusitaniae and Candida pulcherrima by determination of mating type | Journal of Clinical Microbiology | 2005 | 218 | 0 | |||
| Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity | Liver transplantation | 2005 | 548 | 501 | |||
| Pseudovasculitis and corticosteroid therapy | Clinical rheumatology | 2005 | 581 | 267 | |||
| Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae | Antimicrobial Agents and Chemotherapy | 2005 | 204 | 187 | |||
| Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection marker | Yeast | 2004 | 178 | 0 | |||
| Cellular and Gene Therapy for Major Histocompatibility Complex Class II Deficiency | News in physiological sciences | 2004 | 110 | 0 | |||
| A new DR7-DQ8 haplotype resulting from a recombination between the DQA1 and DQB1 loci in a leukemic patient of Caucasoid origin | Immunogenetics | 2004 | 256 | 0 | |||
| Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes | European Journal of Immunology | 2004 | 271 | 253 | |||
| Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors | Blood | 2003 | 309 | 313 | |||
| Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter | Antimicrobial Agents and Chemotherapy | 2003 | 193 | 271 | |||
| Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency | Molecular therapy | 2002 | 647 | 0 | |||
| Selection of unrelated bone marrow donors by serology, molecular typing and cellular assays | Transplant Immunology | 2002 | 161 | 0 | |||
| Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP | Molecular and cellular biology | 2001 | 532 | 0 | |||
| A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y | Molecular and cellular biology | 2000 | 664 | 0 | |||
| Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter | Journal of Molecular Biology | 2000 | 666 | 0 | |||
| Molecular genetics of the Bare lymphocyte syndrome | Reviews in immunogenetics | 2000 | 572 | 0 | |||
| Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression | Immunological reviews | 2000 | 668 | 0 | |||
| CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex | Genes & development | 2000 | 490 | 0 | |||
| The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expression | Microbes and infection | 1999 | 598 | 0 | |||
| CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes | International immunology | 1999 | 614 | 0 | |||
| Genetic and molecular definition of complementation group D in MHC class II deficiency | Human molecular genetics | 1998 | 635 | 0 | |||
| MHC class II deficiency: definition of a new complementation group | Immunobiology | 1997 | 622 | 0 | |||
| Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency | Human mutation | 1997 | 625 | 0 | |||
| Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency | The New England journal of medicine | 1997 | 644 | 0 |
